Abiopharma

🔍 Parallel49 Equity, ULC (Executive)

Company: CPI Card Group Inc. (PMTS)

Report Date: 2026-09-14

Detailed Transactions and Holdings:

• Sold 2,687,921 shares of Common Stock at $20.425 per share (Direct)
  Date: 2026-09-14 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F3

Footnotes:

• F1: The shares were sold pursuant to that certain Underwriting Agreement between the Reporting Person, the Issuer and the underwriters named therein, dated September 10, 2026, pursuant to which the Reporting Person sold the shares to the underwriters for a price $20.425. The underwriters sold the shares at a price to the public of $21.50.
• F2: 1,690,238 shares reported on this line were sold by Tricor Pacific Capital Partners (Fund IV), LP, following which sale, Tricor Pacific Capital Partners (Fund IV), LP holds 0 shares of common stock of the Company. 997,683 shares reported on this line were sold by Tricor Pacific Capital Partners (Fund IV) US, LP, following which sale, Tricor Pacific Capital Partners (Fund IV) US, LP holds 0 shares of common stock of the Company. Each of Tricor Pacific Capital Partners (Fund IV), LP and Tricor Pacific Capital Partners (Fund IV) US, LP (together, the "Tricor Funds") is managed by Parallel49 Equity, ULC (formerly Tricor Pacific Capital Partners (Fund IV), ULC), as the general partner.
• F3: Bradley Seaman, J. Trevor Johnstone and Roderick Senft are the sole members of an investment committee of the Tricor Funds that has the power to vote or dispose of the shares held by the Tricor Funds. Each member of the investment committee expressly disclaims any beneficial ownership of any shares of common stock held by the Tricor Funds.